Fredun Pharmaceuticals Limited

Web: fredungroup.com NSE: FREDUN BSE: 539730 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1490 2(0%)

Near 52W High of 1590

Volume

Open

722

High

740

Low

722

1,488

VWAP

52 Week High

1,590

52 Week Low

1,400

Viand Research Rating

Quality Score

61/100

Growth Score

69/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,465

No. of Shares

1.65

P/E

19.59

P/B

2.65

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

13.52

ROCE

Profit Growth

Listing Date

Promoter Holding

44.57%

FII Holding

1.06%

DII Holding

2.94%

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jul 2026	Jun 2026	Apr 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 44.57%	(0.01) 44.57%	(0.41) 44.57%	(1.11) 44.17%	(-5.91) 43.06%	(0.01) 48.93%	(0.01) 48.93%	(0.01) 48.93%	(0.01) 48.93%	(-0.21) 48.93%	(0.01) 49.17%	(0.01) 49.17%	(-0.21) 49.16%	(-0.31) 49.31%	(-0.51) 49.62%	(-0.21) 50.15%	(-0.71) 50.34%	(0.01) 51.04%	(-0.21) 51.04%	(0.01) 51.27%	(0.01) 51.27%
FIIs	(0.01) 1.06%	(0.01) 1.06%	(0.01) 1.06%	(0.61) 1.06%	(0.51) 0.46%	(0.01) 0.01%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 2.94%	(0.11) 2.94%	(0.01) 2.81%	(-0.71) 2.83%	(1.91) 3.48%	(0.01) 1.61%	(0.01) 1.59%	(0.01) 1.59%	(0.01) 1.59%	(0.01) 1.59%	(0.01) 1.60%	(0.01) 1.60%	(0.01) 1.60%	(0.01) 1.60%	(0.01) 1.64%	(0.01) 1.65%	(0.01) 1.66%	(0.01) 1.68%	(0.01) 1.68%	(0.01) 1.69%	(0.01) 1.69%
Public	51.43%	51.45%	51.56%	51.94%	53.00%	49.46%	49.49%	49.47%	49.47%	49.47%	49.23%	49.24%	49.24%	49.08%	48.74%	48.20%	48.00%	47.27%	47.27%	47.04%	47.04%
No. of Shareholders	9,598	8,903	8,308	8,338	8,765	8,120	7,906	7,976	8,121	8,018	7,511	7,507	6,837	6,313	4,625	4,521	4,138	3,901	3,690	3,620	3,573

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	228	213	161	145	120	167	102.7	0	78.82	118.03	87	81.98	62.05	79.81	77.96	70.32	48.42	71.85	54.23	54.76
Sales Growth % (YoY)	-	27.3%	-	-	-	-	18%	-	27%	47.9%	11.6%	16.6%	28.2%	11.1%	43.8%	28.4%	7%	69.5%	19%	63%
Sales Growth % (QoQ)	7%	32.3%	11%	20.8%	-28.1%	62.6%	100%	-100%	-33.2%	35.7%	6.1%	32.1%	-22.3%	2.4%	10.9%	45.2%	-32.6%	32.5%	-1%	-
Expenses	196	184	135	123	103	150	89.48	0	68.34	106.87	76.48	72.37	54.44	67.55	70.66	63.52	44.55	66.46	49.88	50.68
Operating Profit	33	29	26	22	17	17	13.22	0	10.48	11.16	10.52	9.61	7.61	12.26	7.3	6.8	3.87	5.39	4.35	4.08
OPM %	14	14	16	15	14	10	12.87	0	13.3	9.46	12.09	11.72	12.26	15.36	9.36	9.67	7.99	7.5	8.02	7.45
Other Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest	9	14	11	8	7	8	5	0	3.91	4.37	3.77	2.9	2.61	3.55	1.95	1.86	1.91	1.72	1.25	1.05
Depreciation	4	3	2	2	1	2	1.09	0	1.05	0.96	0.99	0.94	0.92	0.7	0.74	0.72	0.65	0.58	0.55	0.52
Profit before tax	21	11	14	13	9	7	7.13	0	5.52	5.83	5.76	5.77	4.08	8.01	4.61	4.22	1.31	3.09	2.55	2.51
Tax %	36	4	25	26	25	17	25.25	0	25.18	13.38	26.74	31.72	41.18	51.44	25.16	25.12	27.48	25.57	26.67	26.69
Net Profit	13	11	10	9	7	6	5.33	0	4.13	5.06	4.22	3.94	2.4	3.89	3.46	3.15	0.94	2.3	1.87	1.84
Net Profit Growth % (QoQ)	18.2%	10%	11.1%	28.6%	16.7%	12.6%	100%	-100%	-18.4%	19.9%	7.1%	64.2%	-38.3%	12.4%	9.8%	235.1%	-59.1%	23%	1.6%	-
Net Profit Growth % (YoY)	85.7%	83.3%	87.6%	100%	69.5%	18.6%	26.3%	-100%	72.1%	30.1%	22%	25.1%	155.3%	69.1%	85%	71.2%	-	-	-	-
TTM Net Profit	43	37	32	27.33	18.33	15.46	14.52	13.41	17.35	15.62	14.45	13.69	12.9	11.44	9.85	8.26	6.95	6.01	3.71	0
EPS in Rs	7.96	6.57	6.51	6.64	4.77	4.23	11.29	0	8.75	10.76	8.98	8.41	5.24	8.58	7.66	7.07	2.11	5.19	4.22	4.61

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	635	454	348	275	222	134	113	97	60	57	42	25	21	15
Sales Growth %	40%	-	26.8%	23.6%	65.9%	18.7%	16.2%	62.9%	5.2%	34%	67.1%	18.8%	41.1%	29.1%
Expenses	545	401	310	247	208	126	104	87	54	53	38	24	20	14
Operating Profit	91	52	38	28	14	8	8	10	6	3	4	2	1	1
OPM %	14	12	11	10	6	6	7	11	10	6	9	7	7	9
Other Income	4	2	1	2	2	1	1	0	0	2	1	0	0	0
Interest	39	22	14	9	5	4	4	3	2	2	2	1	1	1
Depreciation	8	5	4	3	2	2	2	1	1	1	1	1	1	0
Profit before tax	47	27	21	18	9	3	2	6	3	2	2	1	0	0
Tax %	31	28	27	38	26	37	24	28	34	36	42	52	47	80
Net Profit	33	20	16	11	6	2	2	4	2	1	1	0	0	0
Net Profit Growth %	65%	25%	45.5%	83.3%	200%	-	-50%	100%	100%	-	-	-	-	-
EPS in Rs	19.89	13.9	33.22	23.85	14.3	5.04	4.76	11.18	5.11	6.08	4.55	1.11	1.02	0.04
Dividend Payout %	1	2	2	3	5	14	14	6	12	10	13	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	12	-17	0	-14	-2	0	-11	1	17	4	3	2	-1	1
Cash from Investing Activity	-74	-6	-8	-9	-4	-1	-1	-5	-8	-7	-6	-3	-2	-1
Cash from Financing Activity	121	27	6	25	7	-1	14	4	-8	3	3	1	2	0
Net Cash Flow	60	4	-2	1	1	-2	2	0	1	-1	1	0	0	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	5	5	5	5	5	5	4	4	4	4	3	2	2	2	2	2
Reserves	273	153	137	126	117	92	64	39	37	35	19	2	1	0	0	0
Borrowings	222	171	167	137	106	87	53	40	35	19	10	21	16	9	7	5
Other Liabilities	142	136	179	87	81	74	66	79	65	47	47	30	24	11	8	7
Total Liabilities	642	464	487	355	308	257	187	162	141	105	79	56	43	23	18	15
Fixed Assets	118	66	53	48	47	39	32	30	31	31	16	16	15	8	7	6
CWIP	0	0	0	0	0	0	0	0	0	0	11	4	0	1	0	0
Investments	2	2	2	1	1	0	0	0	0	0	0	0	0	0	0	0
Other Assets	522	397	433	306	260	218	155	131	110	74	52	36	29	14	11	9
Total Assets	642	464	487	355	308	257	187	162	141	105	79	56	43	23	18	15

Delivery

Delivery Data: FREDUN

#	Date	1400 14% 1590	Value (Cr)	Q/T 10	Del 56	Del 2
1	4-Sep	1471	2	12	61	1
2	3-Sep	1488	1	10	54	1
3	2-Sep	1506	1	7	58	1
4	1-Sep	1498	4	10	52	2
5	31-Aug	1447	3	9	54	2
6	28-Aug	1477	2	10	60	1
7	27-Aug	1493	3	11	54	2
8	26-Aug	1494	5	10	48	2
9	25-Aug	1449	2	10	62	1
10	24-Aug	1431	3	10	63	2
11	21-Aug	1435	1	8	64	1
12	20-Aug	1472	3	10	60	2
13	19-Aug	1428	2	9	55	1
14	18-Aug	1437	4	12	49	2
15	17-Aug	1474	2	14	60	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	2,465c	18c	0.72
03-Sep	2,483c	20c	0.82
01-Sep	2,463c	62c	2.58
31-Aug	2,401c	60c	2.45
27-Aug	2,461c	32c	1.31
26-Aug	2,429c	31c	1.29
25-Aug	2,398c	46c	1.97
24-Aug	2,352c	20c	0.82
21-Aug	2,371c	8c	0.34
19-Aug	2,363c	51c	2.13
18-Aug	2,415c	41c	1.68
17-Aug	2,456c	0	0

Stock Checklist

Price is above from 52 week high low average: 48%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView